Last update 24 Jun 2024

Sotrastaurin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Sotrastaurin (USAN/INN), Sotrastaurin acetate, AEB 071
+ [3]
Target
Mechanism
PKC inhibitors(Protein kinase C inhibitors), Immunosuppressants
Active Indication-
Originator Organization
Active Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-

Structure

Molecular FormulaC25H22N6O2
InChIKeyOAVGBZOFDPFGPJ-UHFFFAOYSA-N
CAS Registry425637-18-9

External Link

KEGGWikiATCDrug Bank
D09671--

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
B-Cell Prolymphocytic LeukemiaPhase 2-12 Mar 2015
Chronic lymphocytic leukaemia refractoryPhase 2-12 Mar 2015
Mantle cell lymphoma recurrentPhase 2-12 Mar 2015
Recurrent Chronic Lymphoid LeukemiaPhase 2-12 Mar 2015
Rhabdoid Tumor of the CNSPhase 2-12 Mar 2015
Richter's syndromePhase 2-12 Mar 2015
Small Lymphocytic LymphomaPhase 2-12 Mar 2015
Uveal MelanomaPhase 2
US
01 Aug 2013
Uveal MelanomaPhase 2
FR
01 Aug 2013
Uveal MelanomaPhase 2
DE
01 Aug 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
118
dhgbsanity(jthnstcfpt) = pizntioczu jsshfxbnzg (snxeamleko )
-
20 May 2014
Phase 2
-
298
qsqtvcauki(zubnfzqjrf) = hysztnpfyo wzkthybywc (avddazdnef )
-
01 Jul 2013
qsqtvcauki(zubnfzqjrf) = nmxqmwquaf wzkthybywc (avddazdnef )
Phase 2
124
Tacrolimus
kkxqixldxv(ckvewenwrx) = The most common adverse events were gastrointestinal disorders (control: 63.6%; sotrastaurin: 88.9%) which led to study-medication discontinuation in two sotrastaurin patients moreviktmc (tbiogpyiwp )
-
01 Jul 2011
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free